Encompass Health Corp (EHC)
Data as of , from SEC Form 4 filings.
See up to 3 months of EHC. The 7-day demo opens the 1M and 3M ranges and puts EHC on your watchlist.
Start 7-day demoLatest EHC insider trades
About Encompass Health Corp (EHC)
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
- BIRMINGHAM, AL
- 29,944
- 1989
- XNYS
EHC Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 6 | 210,992 | $26.43M |
| Option exercise | 2 | 9,716 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
EHC insider transactions (Form 4)
46114 Form 4 filings on record, the earliest from Oct 17, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mark J. Tarr - Officer | Grant or award | Encompass Health Common Stock | 100,946 footnote F1 | $0.00 | - | |
| Mark J. Tarr - Officer | Grant or award | Encompass Health Common Stock | 12,796 footnote F2 | $0.00 | - | |
| ||||||
| Grant or award | Encompass Health Common Stock | 7,690 footnote F1 | $0.00 | - | ||
| Grant or award | Encompass Health Common Stock | 1,430 footnote F2 | $0.00 | - | ||
| ||||||
| Patrick William Tuer - Officer | Grant or award | Encompass Health Common Stock | 10,254 footnote F1 | $0.00 | - | |
| Patrick William Tuer - Officer | Grant or award | Encompass Health Common Stock | 3,790 footnote F2 | $0.00 | - | |
| ||||||
| Mark J. Tarr - Officer | Open-market sale | Encompass Health Common Stock | 213 | $113.58 | $24K | |
| Mark J. Tarr - Officer | Open-market sale | Encompass Health Common Stock | 16,216 | $108.03 footnote F1 | $1.75M | |
| Mark J. Tarr - Officer | Open-market sale | Encompass Health Common Stock | 13,231 | $108.80 footnote F2 | $1.44M | |
| Mark J. Tarr - Officer | Open-market sale | Encompass Health Common Stock | 15,584 | $110.07 footnote F3 | $1.72M | |
| Mark J. Tarr - Officer | Open-market sale | Encompass Health Common Stock | 10,954 | $110.92 footnote F4 | $1.22M | |
| Mark J. Tarr - Officer | Open-market sale | Encompass Health Common Stock | 6,057 | $111.89 footnote F5 | $678K | |
| Mark J. Tarr - Officer | Open-market sale | Encompass Health Common Stock | 87,745 | $113.09 footnote F6 | $9.92M | |
| ||||||
| Patrick William Tuer - Officer | Open-market sale | Encompass Health Common Stock | 2,804 | $107.62 footnote F1 | $302K | |
| ||||||
| Cain A. Hayes - Director | Grant or award | Encompass Health Common Stock | 457 footnote F1 | $0.00 | - | |
| ||||||
| Greg D. Carmichael - Director | Grant or award | Encompass Health Common Stock | 28 footnote F1 | $0.00 | - | |
| ||||||
| Joan E. Herman - Director | Grant or award | Encompass Health Common Stock | 87 footnote F1 | $0.00 | - | |
| ||||||
| Grant or award | Encompass Health Common Stock | 87 footnote F1 | $0.00 | - | ||
| ||||||
| Grant or award | Encompass Health Common Stock | 17 footnote F1 | $0.00 | - | ||
| ||||||
| Grant or award | Encompass Health Common Stock | 40 footnote F1 | $0.00 | - | ||
| ||||||
| Terrance Williams - Director | Grant or award | Encompass Health Common Stock | 28 footnote F1 | $0.00 | - | |
| ||||||
| Edward M. Christie III - Director | Grant or award | Encompass Health Common Stock | 9 footnote F1 | $0.00 | - | |
| Edward M. Christie III - Director | Grant or award | Encompass Health Common Stock | 269 footnote F2 | $102.82 footnote F3 | $28K | |
| ||||||
| Christopher R. Reidy - Director | Grant or award | Encompass Health Common Stock | 19 footnote F1 | $0.00 | - | |
| Christopher R. Reidy - Director | Grant or award | Encompass Health Common Stock | 346 footnote F2 | $103.07 footnote F3 | $36K | |
| ||||||
| Grant or award | Encompass Health Common Stock | 14 footnote F1 | $0.00 | - | ||
| ||||||
| Terrance Williams - Director | Grant or award | Encompass Health Common Stock | 23 footnote F1 | $0.00 | - | |
| ||||||
| Edward M. Christie III - Director | Grant or award | Encompass Health Common Stock | 7 footnote F1 | $0.00 | - | |
| Edward M. Christie III - Director | Grant or award | Encompass Health Common Stock | 223 footnote F2 | $123.21 footnote F3 | $27K | |
| ||||||
| Grant or award | Encompass Health Common Stock | 33 footnote F1 | $0.00 | - | ||
| ||||||
| Christopher R. Reidy - Director | Grant or award | Encompass Health Common Stock | 16 footnote F1 | $0.00 | - | |
| Christopher R. Reidy - Director | Grant or award | Encompass Health Common Stock | 288 footnote F2 | $123.23 footnote F3 | $35K | |
| ||||||
| Joan E. Herman - Director | Grant or award | Encompass Health Common Stock | 73 footnote F1 | $0.00 | - | |
| ||||||
| Greg D. Carmichael - Director | Grant or award | Encompass Health Common Stock | 23 footnote F1 | $0.00 | - | |
| ||||||
| Grant or award | Encompass Health Common Stock | 73 footnote F1 | $0.00 | - | ||
| ||||||
| Patrick William Tuer - Officer | Open-market sale | Encompass Health Common Stock | 1,020 | $123.59 | $126K | |
| Douglas E. Coltharp - Officer | Gift | Encompass Health Common Stock | 27,480 | $0.00 | - | |
| Douglas E. Coltharp - Officer | Gift | Encompass Health Common Stock | 27,480 | $0.00 | - | |
| Grant or award | Encompass Health Common Stock | 15 | $0.00 | - | ||
| Terrance Williams - Director | Grant or award | Encompass Health Common Stock | 24 | $0.00 | - | |
| Patricia Anne Maryland - Director | Grant or award | Encompass Health Common Stock | 24 | $0.00 | - | |
| Edward M. Christie III - Director | Grant or award | Encompass Health Common Stock | 8 | $0.00 | - | |
| Edward M. Christie III - Director | Grant or award | Encompass Health Common Stock | 260 | $106.48 | $28K | |
| Grant or award | Encompass Health Common Stock | 34 | $0.00 | - | ||
| Christopher R. Reidy - Director | Grant or award | Encompass Health Common Stock | 17 | $0.00 | - | |
| Christopher R. Reidy - Director | Grant or award | Encompass Health Common Stock | 333 | $106.89 | $36K | |
See every EHC filing on record
These pages show the latest 90 of 114 Form 4 filings on record. The 7-day demo shows all 114, and sign-up brings you back to this table.
Recent EHC Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| John Patrick Darby | Officer | 4,858 | $588K | View on EDGAR | |
| Mark Tarr | Officer | 173,148 | $21.72M |
Stock trades in EHC disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
| Sale |
EHC insider trading FAQ
What is the latest insider trade for EHC?
Encompass Health Corp (EHC) had 5 insider filings in the last 90 days, with the most recent on 2026-09-01. The full record for EHC runs to 114 Form 4 filings, the earliest from 2024-10-17. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying EHC stock?
No insider purchases of EHC were filed in the last 90 days.
How many insiders are selling EHC stock?
6 insider sales of EHC were filed in the last 90 days, totaling $26.43M.
Where can I see EHC SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects EHC Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Andrew L. Price view on EDGAR
- - John Patrick Darby view on EDGAR
- - Douglas E. Coltharp view on EDGAR
- - Mark J. Tarr view on EDGAR
- - John Patrick Darby view on EDGAR
- - Christopher R. Reidy view on EDGAR
- - Edward M. Christie III view on EDGAR
- - Terrance Williams view on EDGAR
- - Nancy M. Schlichting view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where EHC's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow EHC with a 7-day demo
- EHC on your watchlist
- Every EHC Form 4 filing on record
- Up to 3 months of EHC price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive